![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | CD37 | Human | 1,2-dimethylhydrazine | increases expression | ISO | Cd37 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of CD37 mRNA | CTD | PMID:22206623 | CD37 | Human | 1,2-dimethylhydrazine | multiple interactions | ISO | Cd37 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of CD37 mRNA | CTD | PMID:22206623 | CD37 | Human | 17alpha-ethynylestradiol | affects expression | ISO | Cd37 (Mus musculus) | 6480464 | Ethinyl Estradiol affects the expression of CD37 mRNA | CTD | PMID:17555576 | CD37 | Human | 17alpha-ethynylestradiol | increases expression | ISO | Cd37 (Rattus norvegicus) | 6480464 | Ethinyl Estradiol results in increased expression of CD37 mRNA | CTD | PMID:15834898 and PMID:17351261 | CD37 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Cd37 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CD37 mRNA | CTD | PMID:21570461 | CD37 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Cd37 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CD37 mRNA | CTD | PMID:34747641 | CD37 | Human | 2,6-di-tert-butyl-4-methylphenol | decreases expression | ISO | Cd37 (Mus musculus) | 6480464 | Butylated Hydroxytoluene results in decreased expression of CD37 mRNA | CTD | PMID:19925653 | CD37 | Human | 2-butoxyethanol | decreases expression | ISO | Cd37 (Mus musculus) | 6480464 | n-butoxyethanol results in decreased expression of CD37 mRNA | CTD | PMID:19812364 | CD37 | Human | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Cd37 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of CD37 mRNA | CTD | PMID:26251327 | CD37 | Human | 4,4'-diaminodiphenylmethane | increases expression | ISO | Cd37 (Rattus norvegicus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in increased expression of CD37 mRNA | CTD | PMID:30723492 | CD37 | Human | 4-hydroxyphenyl retinamide | decreases expression | ISO | Cd37 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of CD37 mRNA | CTD | PMID:28973697 | CD37 | Human | 9-cis-retinoic acid | increases expression | ISO | Cd37 (Rattus norvegicus) | 6480464 | Alitretinoin results in increased expression of CD37 mRNA | CTD | PMID:16648578 | CD37 | Human | acetamide | increases expression | ISO | Cd37 (Rattus norvegicus) | 6480464 | acetamide results in increased expression of CD37 mRNA | CTD | PMID:31881176 | CD37 | Human | all-trans-retinoic acid | decreases expression | ISO | Cd37 (Mus musculus) | 6480464 | Tretinoin results in decreased expression of CD37 mRNA | CTD | PMID:16604517 | CD37 | Human | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of CD37 mRNA | CTD | PMID:33167477 | CD37 | Human | alpha-Zearalanol | increases expression | ISO | Cd37 (Rattus norvegicus) | 6480464 | Zeranol results in increased expression of CD37 mRNA | CTD | PMID:35163327 | CD37 | Human | ammonium chloride | affects expression | ISO | Cd37 (Rattus norvegicus) | 6480464 | Ammonium Chloride affects the expression of CD37 mRNA | CTD | PMID:16483693 | CD37 | Human | antirheumatic drug | decreases expression | EXP | | 6480464 | Antirheumatic Agents results in decreased expression of CD37 mRNA | CTD | PMID:24449571 | CD37 | Human | aristolochic acid A | increases expression | EXP | | 6480464 | aristolochic acid I results in increased expression of CD37 mRNA | CTD | PMID:33212167 | CD37 | Human | arsane | decreases methylation | EXP | | 6480464 | Arsenic results in decreased methylation of CD37 gene | CTD | PMID:31135185 | CD37 | Human | arsenic atom | decreases methylation | EXP | | 6480464 | Arsenic results in decreased methylation of CD37 gene | CTD | PMID:31135185 | CD37 | Human | atrazine | decreases expression | ISO | Cd37 (Rattus norvegicus) | 6480464 | Atrazine results in decreased expression of CD37 mRNA | CTD | PMID:36841081 | CD37 | Human | benzo[a]pyrene | decreases expression | ISO | Cd37 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of CD37 mRNA | CTD | PMID:21569818 | CD37 | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of CD37 3' UTR | CTD | PMID:27901495 | CD37 | Human | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of CD37 exon and Benzo(a)pyrene results in decreased methylation of CD37 promoter | CTD | PMID:27901495 | CD37 | Human | benzo[a]pyrene | multiple interactions | ISO | Cd37 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CD37 mRNA | CTD | PMID:27858113 | CD37 | Human | benzo[b]fluoranthene | multiple interactions | ISO | Cd37 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CD37 mRNA | CTD | PMID:27858113 | CD37 | Human | beta-lapachone | decreases expression | EXP | | 6480464 | beta-lapachone results in decreased expression of CD37 mRNA | CTD | PMID:38218311 | CD37 | Human | bexarotene | increases expression | ISO | Cd37 (Rattus norvegicus) | 6480464 | bexarotene results in increased expression of CD37 mRNA | CTD | PMID:16648578 | CD37 | Human | bis(2-ethylhexyl) phthalate | decreases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in decreased expression of CD37 mRNA | CTD | PMID:31163220 | CD37 | Human | bis(2-ethylhexyl) phthalate | decreases expression | ISO | Cd37 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in decreased expression of CD37 mRNA | CTD | PMID:34319233 | CD37 | Human | bisphenol A | decreases expression | ISO | Cd37 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of CD37 mRNA | CTD | PMID:25181051 more ... | CD37 | Human | bisphenol A | increases expression | ISO | Cd37 (Mus musculus) | 6480464 | bisphenol A results in increased expression of CD37 mRNA | CTD | PMID:32156529 and PMID:38701888 | CD37 | Human | buta-1,3-diene | decreases expression | ISO | Cd37 (Mus musculus) | 6480464 | 1 and 3-butadiene results in decreased expression of CD37 mRNA | CTD | PMID:29038090 | CD37 | Human | carbon nanotube | increases expression | ISO | Cd37 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | CD37 | Human | chloroprene | decreases expression | ISO | Cd37 (Mus musculus) | 6480464 | Chloroprene results in decreased expression of CD37 mRNA | CTD | PMID:23125180 | CD37 | Human | choline | multiple interactions | ISO | Cd37 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CD37 mRNA and [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CD37 gene | CTD | PMID:20938992 | CD37 | Human | chrysene | multiple interactions | ISO | Cd37 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CD37 mRNA | CTD | PMID:27858113 | CD37 | Human | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of CD37 mRNA | CTD | PMID:27392435 | CD37 | Human | copper atom | decreases expression | ISO | Cd37 (Rattus norvegicus) | 6480464 | Copper results in decreased expression of CD37 mRNA | CTD | PMID:30556269 | CD37 | Human | copper(0) | decreases expression | ISO | Cd37 (Rattus norvegicus) | 6480464 | Copper results in decreased expression of CD37 mRNA | CTD | PMID:30556269 | CD37 | Human | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of CD37 mRNA | CTD | PMID:19549813 | CD37 | Human | Cuprizon | increases expression | ISO | Cd37 (Rattus norvegicus) | 6480464 | Cuprizone results in increased expression of CD37 mRNA | CTD | PMID:27523638 | CD37 | Human | dichloromethane | decreases expression | ISO | Cd37 (Rattus norvegicus) | 6480464 | Methylene Chloride results in decreased expression of CD37 mRNA | CTD | PMID:20955722 | CD37 | Human | dimethylarsinic acid | multiple interactions | ISO | Cd37 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD37 mRNA | CTD | PMID:34876320 | CD37 | Human | diuron | decreases expression | EXP | | 6480464 | Diuron results in decreased expression of CD37 mRNA | CTD | PMID:35967413 | CD37 | Human | ethylbenzene | decreases expression | ISO | Cd37 (Rattus norvegicus) | 6480464 | ethylbenzene results in decreased expression of CD37 mRNA | CTD | PMID:20955722 | CD37 | Human | flavonoids | increases expression | ISO | Cd37 (Rattus norvegicus) | 6480464 | Flavonoids results in increased expression of CD37 mRNA | CTD | PMID:18035473 | CD37 | Human | folic acid | multiple interactions | ISO | Cd37 (Mus musculus) | 6480464 | [1 more ... | CTD | PMID:20938992 and PMID:22206623 | CD37 | Human | folic acid | increases expression | ISO | Cd37 (Mus musculus) | 6480464 | Folic Acid results in increased expression of CD37 mRNA | CTD | PMID:25629700 | CD37 | Human | gentamycin | increases expression | ISO | Cd37 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of CD37 mRNA | CTD | PMID:22061828 | CD37 | Human | gentamycin | decreases expression | ISO | Cd37 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of CD37 mRNA | CTD | PMID:33387578 | CD37 | Human | glycidol | increases expression | ISO | Cd37 (Rattus norvegicus) | 6480464 | glycidol results in increased expression of CD37 mRNA | CTD | PMID:24915197 | CD37 | Human | hexachlorobenzene | decreases expression | ISO | Cd37 (Rattus norvegicus) | 6480464 | Hexachlorobenzene results in decreased expression of CD37 mRNA | CTD | PMID:15159207 | CD37 | Human | isotretinoin | increases expression | EXP | | 6480464 | Isotretinoin results in increased expression of CD37 mRNA | CTD | PMID:20436886 | CD37 | Human | L-methionine | multiple interactions | ISO | Cd37 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CD37 mRNA and [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CD37 gene | CTD | PMID:20938992 | CD37 | Human | lead(0) | decreases expression | EXP | | 6480464 | Lead results in decreased expression of CD37 mRNA | CTD | PMID:19921347 | CD37 | Human | methotrexate | affects expression | ISO | Cd37 (Mus musculus) | 6480464 | Methotrexate affects the expression of CD37 mRNA | CTD | PMID:18502557 | CD37 | Human | methylarsonic acid | multiple interactions | ISO | Cd37 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD37 mRNA | CTD | PMID:34876320 | CD37 | Human | N-nitrosodiethylamine | multiple interactions | ISO | Cd37 (Mus musculus) | 6480464 | [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of CD37 gene | CTD | PMID:23968726 | CD37 | Human | nickel atom | increases expression | EXP | | 6480464 | Nickel results in increased expression of CD37 mRNA | CTD | PMID:24768652 and PMID:25583101 | CD37 | Human | nitrates | multiple interactions | ISO | Cd37 (Mus musculus) | 6480464 | [Particulate Matter results in increased abundance of Nitrates] which results in increased expression of CD37 mRNA | CTD | PMID:35964746 | CD37 | Human | ozone | decreases expression | ISO | Cd37 (Mus musculus) | 6480464 | Ozone results in decreased expression of CD37 mRNA | CTD | PMID:12763052 | CD37 | Human | ozone | multiple interactions | ISO | Cd37 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of CD37 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of CD37 mRNA | CTD | PMID:34911549 | CD37 | Human | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of CD37 mRNA | CTD | PMID:22230336 | CD37 | Human | paracetamol | decreases expression | ISO | Cd37 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of CD37 mRNA | CTD | PMID:33387578 | CD37 | Human | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of CD37 mRNA | CTD | PMID:26690555 | CD37 | Human | piperonyl butoxide | multiple interactions | ISO | Cd37 (Mus musculus) | 6480464 | [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of CD37 gene | CTD | PMID:23968726 | CD37 | Human | prothioconazole | decreases expression | EXP | | 6480464 | prothioconazole results in decreased expression of CD37 mRNA | CTD | PMID:35048155 | CD37 | Human | silicon dioxide | decreases expression | ISO | Cd37 (Mus musculus) | 6480464 | Silicon Dioxide results in decreased expression of CD37 mRNA | CTD | PMID:19073995 | CD37 | Human | sodium arsenate | multiple interactions | ISO | Cd37 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD37 mRNA | CTD | PMID:34876320 | CD37 | Human | sodium arsenite | multiple interactions | ISO | Cd37 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD37 mRNA | CTD | PMID:34876320 | CD37 | Human | sodium arsenite | increases expression | ISO | Cd37 (Mus musculus) | 6480464 | sodium arsenite results in increased expression of CD37 mRNA | CTD | PMID:36209798 | CD37 | Human | tamoxifen | affects expression | ISO | Cd37 (Mus musculus) | 6480464 | Tamoxifen affects the expression of CD37 mRNA | CTD | PMID:17555576 | CD37 | Human | Tesaglitazar | increases expression | ISO | Cd37 (Rattus norvegicus) | 6480464 | tesaglitazar results in increased expression of CD37 mRNA | CTD | PMID:21515302 | CD37 | Human | testosterone | decreases expression | EXP | | 6480464 | Testosterone results in decreased expression of CD37 mRNA | CTD | PMID:33359661 | CD37 | Human | tetraphene | multiple interactions | ISO | Cd37 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CD37 mRNA | CTD | PMID:27858113 | CD37 | Human | titanium dioxide | decreases methylation | ISO | Cd37 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of CD37 gene and titanium dioxide results in decreased methylation of CD37 promoter | CTD | PMID:35295148 | CD37 | Human | trichloroethene | decreases expression | ISO | Cd37 (Rattus norvegicus) | 6480464 | Trichloroethylene results in decreased expression of CD37 mRNA | CTD | PMID:20955722 and PMID:33387578 | CD37 | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of CD37 mRNA | CTD | PMID:37042841 | CD37 | Human | triptonide | increases expression | ISO | Cd37 (Mus musculus) | 6480464 | triptonide results in increased expression of CD37 mRNA | CTD | PMID:33045310 | CD37 | Human | troglitazone | increases expression | ISO | Cd37 (Rattus norvegicus) | 6480464 | troglitazone results in increased expression of CD37 mRNA | CTD | PMID:21515302 | CD37 | Human | troglitazone | increases expression | ISO | Cd37 (Mus musculus) | 6480464 | troglitazone results in increased expression of CD37 mRNA | CTD | PMID:28973697 | CD37 | Human | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of CD37 gene | CTD | PMID:29154799 | CD37 | Human | vinclozolin | increases expression | ISO | Cd37 (Rattus norvegicus) | 6480464 | vinclozolin results in increased expression of CD37 mRNA | CTD | PMID:23034163 | |